$TFX (TELEFLEX) — 8-K: Teleflex adds Medtronic cardiovascular chief Sean Salmon to board

Teleflex appointed Sean M. Salmon to its Board of Directors effective September 8, 2026. Salmon most recently served as Executive Vice President and President of Medtronic’s Cardiovascular Portfolio, a business with fiscal 2025 revenue of approximately $12.5 billion. He will serve on the Growth and Operating Committee. Following the appointment, the board has nine directors, eight of whom are independent, and one third of the board has been refreshed in 2026.

Teleflex appointed Sean M. Salmon to its Board of Directors effective September 8, 2026. Salmon most recently served as Executive Vice President and President of Medtronic’s Cardiovascular Portfolio,